Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
49,900
+150 (0.30%)
At close: Apr 29, 2026
HOSE:DBD Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 291,229 | 291,940 | 275,182 | 269,055 | 243,555 | 189,124 |
Depreciation & Amortization | 46,882 | 49,565 | 48,112 | 45,970 | 41,665 | 38,689 |
Other Amortization | 1,456 | 1,456 | - | - | - | - |
Loss (Gain) From Sale of Assets | -37,329 | -32,316 | -38,668 | -40,339 | -13,801 | -5,488 |
Other Operating Activities | 10,497 | 39,370 | 20,898 | 16,952 | 21,843 | 20,760 |
Change in Accounts Receivable | -9,995 | 407.6 | -16,554 | 72,231 | -28,740 | -85,346 |
Change in Inventory | 41,266 | 134,717 | -33,974 | -48,018 | -196,262 | -39,176 |
Change in Accounts Payable | 137,605 | 133,042 | 11,570 | -28,608 | 97,633 | -5,683 |
Change in Other Net Operating Assets | -4,224 | -2,995 | -1,835 | -4,886 | -882.62 | 4,687 |
Operating Cash Flow | 477,388 | 615,187 | 264,730 | 282,356 | 165,012 | 117,568 |
Operating Cash Flow Growth | 81.41% | 132.38% | -6.24% | 71.11% | 40.36% | -44.78% |
Capital Expenditures | -394,505 | -408,573 | -148,745 | -133,694 | -82,828 | -54,636 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 1 |
Investment in Securities | -311,080 | -284,780 | 114,637 | 18,060 | -82,189 | - |
Other Investing Activities | 33,248 | 31,730 | 11,124 | 12,033 | 7,326 | 5,268 |
Investing Cash Flow | -672,338 | -661,624 | -22,984 | -103,601 | -157,691 | -95,227 |
Long-Term Debt Issued | - | 259,895 | 60,380 | 216,778 | - | 50,916 |
Total Debt Issued | 392,223 | 259,895 | 60,380 | 216,778 | - | 50,916 |
Long-Term Debt Repaid | - | -148,594 | -75,733 | -213,511 | -21,029 | -37,162 |
Total Debt Repaid | -163,190 | -148,594 | -75,733 | -213,511 | -21,029 | -37,162 |
Net Debt Issued (Repaid) | 229,033 | 111,301 | -15,354 | 3,267 | -21,029 | 13,754 |
Issuance of Common Stock | 9,355 | 9,355 | - | - | - | - |
Common Dividends Paid | -185,991 | -185,629 | -9.93 | -149,698 | - | -75,553 |
Financing Cash Flow | 52,397 | -64,972 | -15,364 | -146,431 | -21,029 | -61,799 |
Foreign Exchange Rate Adjustments | 11.04 | -6.65 | -21.19 | -49.2 | - | - |
Net Cash Flow | -142,542 | -111,415 | 226,362 | 32,275 | -13,709 | -39,458 |
Free Cash Flow | 82,883 | 206,614 | 115,985 | 148,663 | 82,184 | 62,932 |
Free Cash Flow Growth | -43.41% | 78.14% | -21.98% | 80.89% | 30.59% | -58.91% |
Free Cash Flow Margin | 4.43% | 11.08% | 6.71% | 9.00% | 5.29% | 4.04% |
Free Cash Flow Per Share | - | 2200.91 | 1239.77 | 1589.06 | 878.47 | 672.68 |
Cash Interest Paid | 3,706 | 3,706 | 4,190 | 7,166 | 1,916 | 869.42 |
Cash Income Tax Paid | 24,729 | 24,729 | 63,607 | 38,168 | 55,332 | 52,859 |
Levered Free Cash Flow | 33,755 | 133,790 | 43,338 | 105,962 | 20,718 | -48,957 |
Unlevered Free Cash Flow | 36,463 | 136,194 | 45,875 | 110,336 | 21,915 | -48,129 |
Change in Working Capital | 164,652 | 265,172 | -40,793 | -9,281 | -128,251 | -125,517 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.